This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Britt, W J Articles by Stephens, E B Search for Related Content PubMed PubMed Citation Articles by Britt, W J Articles by Stephens, E B

 Previous Article  |  Next Article 

J Virol. 1990 March; 64(3): 1079-1085

Cell surface expression of human cytomegalovirus (HCMV) gp55-116 (gB): use of HCMV-recombinant vaccinia virus-infected cells in analysis of the human neutralizing antibody response.

Department of Pediatrics and Microbiology, School of Medicine, University of Alabama, Birmingham 35294.

ABSTRACT

Cell surface expression of the human cytomegalovirus (HCMV) major envelope glycoprotein complex, gp55-116 (gB), was studied by using monoclonal antibodies and an HCMV gp55-116 (gB) recombinant vaccinia virus. HCMV-infected human fibroblasts and recombinant vaccinia virus-infected HeLa cells expresses three electrophoretically distinct proteins of Mr 170,000, 116,000, and 55,000 on their surface. These species have been previously identified within infected cells and purified virions. Two unique neutralizing epitopes were shown to be present on the cell surface gp55-116 (gB). Utilizing HeLa cells infected with the gp55-116 recombinant vaccinia virus as a specific immunosorbent, we have shown that approximately 40 to 70% of the total serum virus-neutralizing activity of a group of individuals with past HCMV infections was directed against this single envelope glycoprotein. The implications of this finding for vaccine development are discussed.

This article has been cited by other articles:

• Yue, Y., Kaur, A., Eberhardt, M. K., Kassis, N., Zhou, S. S., Tarantal, A. F., Barry, P. A. (2007). Immunogenicity and Protective Efficacy of DNA Vaccines Expressing Rhesus Cytomegalovirus Glycoprotein B, Phosphoprotein 65-2, and Viral Interleukin-10 in Rhesus Macaques. J. Virol. 81: 1095-1109 [Abstract] [Full Text]  
• Wang, D., Shenk, T. (2005). Human cytomegalovirus virion protein complex required for epithelial and endothelial cell tropism. Proc. Natl. Acad. Sci. USA 102: 18153-18158 [Abstract] [Full Text]  
• Kinzler, E. R., Compton, T. (2005). Characterization of Human Cytomegalovirus Glycoprotein-Induced Cell-Cell Fusion. J. Virol. 79: 7827-7837 [Abstract] [Full Text]  
• McLean, G. R., Olsen, O. A., Watt, I. N., Rathanaswami, P., Leslie, K. B., Babcook, J. S., Schrader, J. W. (2005). Recognition of Human Cytomegalovirus by Human Primary Immunoglobulins Identifies an Innate Foundation to an Adaptive Immune Response. J. Immunol. 174: 4768-4778 [Abstract] [Full Text]  
• Britt, W. J., Jarvis, M. A., Drummond, D. D., Mach, M. (2005). Antigenic Domain 1 Is Required for Oligomerization of Human Cytomegalovirus Glycoprotein B. J. Virol. 79: 4066-4079 [Abstract] [Full Text]  
• Wang, Z., La Rosa, C., Maas, R., Ly, H., Brewer, J., Mekhoubad, S., Daftarian, P., Longmate, J., Britt, W. J., Diamond, D. J. (2004). Recombinant Modified Vaccinia Virus Ankara Expressing a Soluble Form of Glycoprotein B Causes Durable Immunity and Neutralizing Antibodies against Multiple Strains of Human Cytomegalovirus. J. Virol. 78: 3965-3976 [Abstract] [Full Text]  
• Yue, Y., Zhou, S. S., Barry, P. A. (2003). Antibody responses to rhesus cytomegalovirus glycoprotein B in naturally infected rhesus macaques. J. Gen. Virol. 84: 3371-3379 [Abstract] [Full Text]  
• Burrows, S. R., Elkington, R. A., Miles, J. J., Green, K. J., Walker, S., Haryana, S. M., Moss, D. J., Dunckley, H., Burrows, J. M., Khanna, R. (2003). Promiscuous CTL Recognition of Viral Epitopes on Multiple Human Leukocyte Antigens: Biological Validation of the Proposed HLA A24 Supertype. J. Immunol. 171: 1407-1412 [Abstract] [Full Text]  
• Rasmussen, L., Cowan, C. M. (2003). Neutralizing antibody to gB2 human cytomegalovirus does not prevent reactivation in patients with human immunodeficiency virus infection. J. Gen. Virol. 84: 1853-1857 [Abstract] [Full Text]  
• Gicklhorn, D., Eickmann, M., Meyer, G., Ohlin, M., Radsak, K. (2003). Differential effects of glycoprotein B epitope-specific antibodies on human cytomegalovirus-induced cell-cell fusion. J. Gen. Virol. 84: 1859-1862 [Abstract] [Full Text]  
• Elkington, R., Walker, S., Crough, T., Menzies, M., Tellam, J., Bharadwaj, M., Khanna, R. (2003). Ex Vivo Profiling of CD8+-T-Cell Responses to Human Cytomegalovirus Reveals Broad and Multispecific Reactivities in Healthy Virus Carriers. J. Virol. 77: 5226-5240 [Abstract] [Full Text]  
• Lantto, J., Fletcher, J. M., Ohlin, M. (2002). A divalent antibody format is required for neutralization of human cytomegalovirus via antigenic domain 2 on glycoprotein B. J. Gen. Virol. 83: 2001-2005 [Abstract] [Full Text]  
• Ye, M., Morello, C. S., Spector, D. H. (2002). Strong CD8 T-Cell Responses following Coimmunization with Plasmids Expressing the Dominant pp89 and Subdominant M84 Antigens of Murine Cytomegalovirus Correlate with Long-Term Protection against Subsequent Viral Challenge. J. Virol. 76: 2100-2112 [Abstract] [Full Text]  
• Theiler, R. N., Compton, T. (2002). Distinct Glycoprotein O Complexes Arise in a Post-Golgi Compartment of Cytomegalovirus-Infected Cells. J. Virol. 76: 2890-2898 [Abstract] [Full Text]  
• Franti, M., Aubin, J.-T., De Saint-Maur, G., Kosuge, H., Yamanishi, K., Gautheret-Dejean, A., Garbarg-Chenon, A., Huraux, J.-M., Agut, H. (2002). Immune Reactivity of Human Sera to the Glycoprotein B of Human Herpesvirus 7. J. Clin. Microbiol. 40: 44-51 [Abstract] [Full Text]  
• Mach, M., Kropff, B., Dal Monte, P., Britt, W. (2000). Complex Formation by Human Cytomegalovirus Glycoproteins M (gpUL100) and N (gpUL73). J. Virol. 74: 11881-11892 [Abstract] [Full Text]  
• Speckner, A., Kropff, B., Knör, S., Mach, M. (2000). The antigenic domain 1 of human cytomegalovirus glycoprotein B contains an intramolecular disulphide bond. J. Gen. Virol. 81: 2659-2663 [Abstract] [Full Text]  
• Sanchez, V., Sztul, E., Britt, W. J. (2000). Human Cytomegalovirus pp28 (UL99) Localizes to a Cytoplasmic Compartment Which Overlaps the Endoplasmic Reticulum-Golgi-Intermediate Compartment. J. Virol. 74: 3842-3851 [Abstract] [Full Text]  
• Singh, J., Compton, T. (2000). Characterization of a Panel of Insertion Mutants in Human Cytomegalovirus Glycoprotein B. J. Virol. 74: 1383-1392 [Abstract] [Full Text]  
• Speckner, A., Glykofrydes, D., Ohlin, M., Mach, M. (1999). Antigenic domain 1 of human cytomegalovirus glycoprotein B induces a multitude of different antibodies which, when combined, results in incomplete virus neutralization. J. Gen. Virol. 80: 2183-2191 [Abstract] [Full Text]  
• Jarvis, M. A., Wang, C. E., Meyers, H. L., Smith, P. P., Corless, C. L., Henderson, G. J., Vieira, J., Britt, W. J., Nelson, J. A. (1999). Human Cytomegalovirus Infection of Caco-2 Cells Occurs at the Basolateral Membrane and Is Differentiation State Dependent. J. Virol. 73: 4552-4560 [Abstract] [Full Text]  
• Huber, M. T., Compton, T. (1999). Intracellular Formation and Processing of the Heterotrimeric gH-gL-gO (gCIII) Glycoprotein Envelope Complex of Human Cytomegalovirus. J. Virol. 73: 3886-3892 [Abstract] [Full Text]  
• Klein, M., Schoppel, K., Amvrossiadis, N., Mach, M. (1999). Strain-Specific Neutralization of Human Cytomegalovirus Isolates by Human Sera. J. Virol. 73: 878-886 [Abstract] [Full Text]  
• Huber, M. T., Compton, T. (1998). The Human Cytomegalovirus UL74 Gene Encodes the Third Component of the Glycoprotein H-Glycoprotein L-Containing Envelope Complex. J. Virol. 72: 8191-8197 [Abstract] [Full Text]  
• Sanchez, V., Angeletti, P. C., Engler, J. A., Britt, W. J. (1998). Localization of Human Cytomegalovirus Structural Proteins to the Nuclear Matrix of Infected Human Fibroblasts. J. Virol. 72: 3321-3329 [Abstract] [Full Text]  
• Boyle, K. A., Compton, T. (1998). Receptor-Binding Properties of a Soluble Form of Human Cytomegalovirus Glycoprotein B. J. Virol. 72: 1826-1833 [Abstract] [Full Text]